4/10
11:20 am
mbx
MBX Biosciences, Inc. (NYSE: MBX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $44.00 price target on the stock.
Low
Report
MBX Biosciences, Inc. (NYSE: MBX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $44.00 price target on the stock.
4/10
11:20 am
mbx
MBX Biosciences, Inc. (NYSE: MBX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $44.00 price target on the stock.
Low
Report
MBX Biosciences, Inc. (NYSE: MBX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $44.00 price target on the stock.
4/10
10:45 am
mbx
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $38.00 price target on the stock.
Low
Report
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $38.00 price target on the stock.
4/10
10:45 am
mbx
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $38.00 price target on the stock.
Low
Report
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $38.00 price target on the stock.
4/10
09:31 am
mbx
Rating for MBX
Medium
Report
Rating for MBX
4/10
09:31 am
mbx
Rating for MBX
Medium
Report
Rating for MBX
4/10
09:06 am
mbx
Rating for MBX
Medium
Report
Rating for MBX
4/10
09:06 am
mbx
Rating for MBX
Medium
Report
Rating for MBX